Association of O6-methylguanine-DNA methyltransferase protein expression with postoperative prognosis and adjuvant chemotherapeutic benefits among patients with stage II or III gastric cancer
JAMA Surgery Nov 18, 2017
Cao Y, et al. - Authors aimed to determine the postoperative prognostic significance of methylguanine-DNA methyltransferase (MGMT) in patients with resectable gastric cancer and its responsiveness to fluorouracil-based adjuvant chemotherapy. They recognized that positive expression of MGMT in gastric cancer was an independent, favorable prognostic factor. As per findings, incorporation of MGMT expression into the current TNM staging system could enhance the prognostic accuracy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries